Impact of Aspirin Use on Outcomes in Patients With Hepatocellular Cancer: A Nationwide Analysis

BACKGROUND: Despite the use of new immunotherapies, hepatocellular carcinoma (HCC) has a poor survival rate. Through multiple molecular mechanisms, aspirin (ASA) has demonstrated a reduced incidence of HCC, however, the impact of long-term ASA use on in-hospital outcomes has not been studied. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhaliwal, Armaan, Sohal, Aalam, Bains, Kanwal, Chaudhry, Hunza, Singh, Ishandeep, Kalra, Eva, Arora, Kirti, Dukovic, Dino, Boiles, Alejandro Recio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284635/
https://www.ncbi.nlm.nih.gov/pubmed/37350804
http://dx.doi.org/10.14740/wjon1601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284635/
https://www.ncbi.nlm.nih.gov/pubmed/37350804
http://dx.doi.org/10.14740/wjon1601

Ejemplares similares